MedTrace Logo

Low Versus Standard Volume EXORA Block in Laparoscopic Cholecystectomy

NCT07507799 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-09-02

No results posted yet for this study

Summary

The original EXORA block used high local anesthetic volume (50 mL total), raising concerns about local anesthetic systemic toxicity (LAST). In such a bilaterally administered regional technique, evaluating the efficacy of a reduced-volume approach is warranted to maximize patient safety.

Conditions

  • Pain, Postoperative
  • Post Operative Analgesia

Interventions

PROCEDURE

EXORA block 15

15 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block

PROCEDURE

EXORA block 25

25 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block

Sponsors & Collaborators

  • Fayoum University Hospital

    lead OTHER

Principal Investigators

  • Mohamed A Hamed,, MD · Faculty of medicine, Fayoum university

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-12
Primary Completion
2027-01-01
Completion
2027-01-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07507799 on ClinicalTrials.gov